| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = -$64,945 ) |
| | 2023 | 2017 | ALGOMEDIX, INC. | 16212 BOTHELL EVERETT HWY | MILL CREEK | WA | 98012-1603 | SNOHOMISH | USA | R43CA210759 | Therapeutic TRPA1 Mechanism-Based Treatment of Chemotherapeutic-Induced Neuropathic Pain | 000 | 1 | NIH | 10/1/2022 | -$64,945 |
|
| Issue Date FY: 2022 ( Subtotal = $64,945 ) |
| | 2022 | 2017 | ALGOMEDIX, INC. | 16212 BOTHELL EVERETT HWY | MILL CREEK | WA | 98012-1603 | SNOHOMISH | USA | R44DA044900 | Development of a TRPA1 Antagonist Opioid-Sparing Analgesic for Chronic Pain | 000 | 1 | NIH | 9/26/2022 | $64,945 |
|
| Issue Date FY: 2021 ( Subtotal = -$579,509 ) |
| | 2021 | 2017 | ALGOMEDIX, INC. | 16212 BOTHELL EVERETT HWY | MILL CREEK | WA | 98012-1603 | SNOHOMISH | USA | R44DA044900 | Development of a TRPA1 Antagonist Opioid-Sparing Analgesic for Chronic Pain | 001 | 1 | NIH | 1/26/2021 | -$575,000 |
| | 2021 | 2017 | ALGOMEDIX, INC. | 16212 BOTHELL EVERETT HWY | MILL CREEK | WA | 98012-1603 | SNOHOMISH | USA | R44DA044900 | Development of a TRPA1 Antagonist Opioid-Sparing Analgesic for Chronic Pain | 000 | 1 | NIH | 1/21/2021 | -$4,509 |
|
| Issue Date FY: 2019 ( Subtotal = -$28,007 ) |
| | 2019 | 2017 | ALGOMEDIX, INC. | 16212 BOTHELL EVERETT HWY | MILL CREEK | WA | 98012-1603 | SNOHOMISH | USA | R43CA210759 | Therapeutic TRPA1 Mechanism-Based Treatment of Chemotherapeutic-Induced Neuropathic Pain | 000 | 1 | NIH | 2/21/2019 | -$28,007 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2017 | ALGOMEDIX, INC. | 16212 BOTHELL EVERETT HWY | MILL CREEK | WA | 98012-1603 | SNOHOMISH | USA | R44DA044900 | Development of a TRPA1 Antagonist Opioid-Sparing Analgesic for Chronic Pain | 000 | 1 | NIH | 8/20/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $1,025,462 ) |
| | 2017 | 2017 | ALGOMEDIX, INC. | 16212 BOTHELL EVERETT HWY | MILL CREEK | WA | 98012-1603 | SNOHOMISH | USA | R43CA210759 | Therapeutic TRPA1 Mechanism-Based Treatment of Chemotherapeutic-Induced Neuropathic Pain | 000 | 1 | NIH | 9/21/2017 | $291,147 |
| | 2017 | 2017 | ALGOMEDIX, INC. | 16212 BTHELL-EVT HIWAY STE F280 | MILL CREEK | WA | 98012-0000 | SNOHOMISH | USA | R44DA044900 | Development of a TRPA1 Antagonist Opioid-Sparing Analgesic for Chronic Pain | 000 | 1 | NIH | 8/18/2017 | $734,315 |
| | 2017 | 2015 | ALGOMEDIX, INC. | 16212 BOTHELL EVERETT HWY | MILL CREEK | WA | 98012-1603 | SNOHOMISH | USA | R43DK105716 | TRPC6 Antagonists as Therapeutics for Chronic Kidney Disease | 000 | 1 | NIH | 1/31/2017 | $0 |
|
| Issue Date FY: 2015 ( Subtotal = $296,818 ) |
| | 2015 | 2015 | ALGOMEDIX INC | 16212 BOTHELLEVERETT HIGHWAY | MILL CREEK | WA | 98012 | SNOHOMISH | USA | R43DK105716 | TRPC6 Antagonists as Therapeutics for Chronic Kidney Disease | 000 | 1 | NIH | 9/4/2015 | $296,818 |
|
| Issue Date FY: 2013 ( Subtotal = $313,424 ) |
| | 2013 | 2013 | ALGOMEDIX INC | 16212 BOTHELLEVERETT HIGHWAY | MILL CREEK | WA | 98012 | SNOHOMISH | USA | R43AR065330 | CONTROL OF ARTHRITIC PAIN BY INHIBITION OF TRPA1 ACTIVITY | 000 | 1 | NIH | 9/10/2013 | $313,424 |
|
| Issue Date FY: 2011 ( Subtotal = $316,121 ) |
| | 2011 | 2011 | ALGOMEDIX INC | 16212 BOTHELLEVERETT HIGHWAY | MILL CREEK | WA | 98012 | SNOHOMISH | USA | R43DA031516 | ANALGESICS TARGETING TRPA1 FOR TREATMENT OF CHRONIC PAIN | 000 | 1 | NIH | 7/25/2011 | $316,121 |
|
|
